Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

United Therapeutics Corp (NASDAQ:UTHR)

118.08
Delayed Data
As of Sep 30
 +3.06 / +2.66%
Today’s Change
97.52
Today|||52-Week Range
164.04
-24.60%
Year-to-Date
5 Stocks with Exciting Price-to-Book Ratios
Sep 28 / Zacks.com - Paid Partner Content
3 Great Stocks You Can Buy on Sale
Sep 27 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close115.02
Today’s open115.84
Day’s range114.38 - 118.36
Volume738,654
Average volume (3 months)570,243
Market cap$5.0B
Dividend yield--
Data as of 3:59pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)+102.55%
Earnings growth (this year)+20.00%
Earnings growth (next 5 years)+0.70%
Revenue growth (last year)+13.76%
P/E ratio5.8
Price/Sales5.47
Price/Book3.31

Competitors

 Today’s
change
Today’s
% change
TAROTaro Pharmaceutical ...-2.88-2.54%
TSROTESARO Inc-0.34-0.34%
ENDPEndo International P...-0.78-3.73%
IONSIonis Pharmaceutical...+1.07+3.01%
Data as of 4:14pm ET, 09/30/2016

Financials

Next reporting dateOctober 25, 2016
EPS forecast (this quarter)$3.38
Annual revenue (last year)$1.5B
Annual profit (last year)$651.6M
Net profit margin44.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Martine A. Rothblatt
President &
Chief Operating Officer
Michael Benkowitz
Corporate headquarters
Silver Spring, Maryland

Forecasts

Search for Jobs